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TO THE EDITOR
Acne vulgaris is a very common skin
disorder, affecting to some degree
88–94% of Singaporean adolescents
(Tan et al., 2007; Yosipovitch et al.,
2007). Genetic predisposition is a sig-
nificant risk factor, as illustrated by
familial and twin studies (Bataille
et al., 2002; Ghodsi et al., 2009). The
clinical features of acne include sebor-
rhea, comedone formation, inflam-
matory pustules, nodules, and cysts,
with resultant scarring. Important
pathogenic mechanisms in acne in-
clude increased sebum production,
hyperkeratinization and occlusion of
the follicular duct, proliferation of
Propionibacterium acnes, and an in-
flammatory reaction (Purdy and de
Berker, 2006). P. acnes produces li-
pases, which liberate proinflammatory
fatty acids from sebum and also triggers
a cytokine response.
Filaggrin is expressed in terminally
differentiating keratinocytes and has a
key role in epithelial barrier forma-
tion. Immunostaining demonstrates in-
creased filaggrin expression in the
sebaceous duct and infundibulum of
acne vulgaris skin (Kurokawa et al.,
1988), and P. acnes strains increase
the expression of filaggrin and other
differentiation-specific markers in nor-
mal human epidermal keratinocytes
in vitro and in the suprabasal layers of
human skin explants (Jarrousse et al.,
2007). Similarly, inflammatory cyto-
kines resulted in increased filaggrin
expression in sebaceous gland explants
(Guy and Kealey, 1998). However, it is
not known whether differences in filaggrin
expression represent a primary or second-
ary effect in the pathogenesis of acne.
Null mutations in the filaggrin gene
(FLG) result in reduced filaggrin expres-
sion and cause ichthyosis vulgaris
(Smith et al., 2006). Such mutations
are common in the general population,
being carried by B10% of Europeans
and 7.3% of Singaporean Chinese
(Sandilands et al., 2007; Chen et al.,
personal communication). This high
carrier rate in different populations
suggests a heterozygote advantage,
and it has been proposed that a more
permeable skin barrier may have been
beneficial in evolutionary history (Irvine
and McLean, 2006). The co-existence
of FLG null mutations with other gene
mutations that disrupt epidermal differ-
entiation may increase phenotype se-
verity (Liao et al., 2007; Gruber et al.,
2009). It is also possible that hetero-
zygosity for null mutations has other
effects on skin physiology. Studying a
cohort of 284 European dermatology
patients not selected for dry skin (Ser-
geant et al., 2009) raised the possibility
that carriage of one FLG null mutation
could provide a protective effect
against acne vulgaris. In the SergeantAbbreviations: FLG, filaggrin gene
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study, the odds ratio of acne in the
carrier group was 0.3 (95% confidence
interval 0.1–1.0), but the difference
between these individuals and the
group without FLG mutations did not
reach statistical significance (P¼0.08).
In addition, this study relied on a
recalled history of acne. We therefore
aimed to test the hypothesis that FLG
null mutations are protective against
the development of acne vulgaris by
studying a well-documented group of
patients with acne, and comparing with
a population control group.
A total of 287 Singaporean Chinese
patients presenting with acne vulgaris to
the National Skin Centre, a major der-
matology outpatient facility in Singapore,
were recruited: mean age 22 years (SD
4.8), range 14–50 (27%o20 years of age
and 95% were under 30 years), 76.3%
Table 1. Genotyping results and Fisher’s exact test to investigate the association between FLG null mutations and
acne vulgaris in a case–control study
Genotype1
FLG null mutation
Acne vulgaris cases and
unselected population controls AA Aa aa Total2
Fisher’s
exact test P-value
p.S406X Cases 279 0 0 279 0.524
Controls 438 2 0 440
c.1249insG Cases 276 4 0 280 0.023
Controls 440 0 0 440
c.2282del4 Cases 275 0 0 275 1.000
Controls 436 1 0 437
c.3321delA Cases 277 4 0 281 0.582
Controls 439 10 0 440
p.S1302X Cases 272 0 0 272 0.304
Controls 434 4 0 438
p.S1515X Cases 275 1 0 276 1.000
Controls 438 2 0 440
c.6834del53 Cases 280 1 0 281 0.390
Controls 440 0 0 440
c.6950del8 Cases 278 3 0 281 1.000
Controls 436 4 0 440
p.Q2417X Cases 278 2 0 280 0.151
Controls 440 0 0 440
p.E2422X Cases 278 2 0 280 0.151
Controls 440 0 0 440
c.7945delA Cases 274 2 0 276 0.562
Controls 439 1 0 440
p.S2706X Cases 276 1 0 280 0.160
Controls 431 7 0 438
c.8157delC3 Cases 278 1 0 279 0.388
Controls 440 0 0 440
p.R4307X Cases 278 1 0 279 0.488
Controls 438 1 0 439
Combined FLG null genotype Cases 235 21 0 256 0.783
Controls 402 31 1 434
1AA, homozygous wild type for FLG null mutation; Aa, heterozygous for the stated FLG null mutation or, in the combined null genotype, any one of the
screened mutations; aa, compound heterozygous (i.e., an individual having two different FLG null mutations). The rationale for generating this combined
null genotype is based on the fact that each mutation results in premature termination of the profilaggrin molecule and hence absence of processed filaggrin
(Sandilands et al., 2007).
2The figures in the total column vary because of incomplete genotyping results; all available data have been used for optimal analysis of each individual
variant, but the combined FLG null genotype data include only those individuals for whom all 14 genotype results are available.
3Previously unreported FLG mutations.
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were male. Acne vulgaris symptoms
were reported for a mean of 5.6 years
(SD 4.2), range from o1 to 32 years.
Patients with polycystic ovarian syn-
drome were excluded from this study.
Acne severity was assessed using the
Global Severity Assessment Score (Leh-
mann et al., 2002): 100 patients (34.8%)
had mild acne, 129 (44.9%) had moder-
ate acne, and 58 (20.3%) had severe
acne. DNA samples from 440 unselected
Singaporean Chinese population controls
with a mean age of 44.6 years (SD 14.0),
range 1–80, 44.1% male, for whom
acne vulgaris status was unknown, were
obtained from Singapore Bio-Bank,
Singapore. This study was approved
by the local domain specific ethical
review board in accordance with the
Declaration of Helsinki and all parti-
cipants gave written, informed consent.
Cases and controls were screened for
all 22 population-specific FLG null muta-
tions as recently reported (Chen et al.,
personal communication). In this group
a total of 12 known FLG null mutations
were detected: p.S406X, c.1249insG,
c.2284del4, c.3321delA, p.S1302X, p.S15
15X, c.6950del8, p.Q2417X, p.E2422X,
c.7945delA, p.S2706X, and p.R4307X,
plus two mutations: c.6834del5 and
c.8157delC, which to our knowledge are
previously unreported. Fisher’s exact test
and logistic regression analyses were used
to compare the prevalence of FLG null
mutations between cases and controls,
using the statistical analysis package Stata
(Version 9, Stata for Linux, StataCorp LP,
College Station, TX). Power calculations
were performed using Quanto version
1.2.4 (University of Southern California,
http://hydra.usc.edu/gxe/).
In this study, 8.2% of Singaporean
Chinese acne vulgaris cases carried one or
more FLG null mutations compared with
7.3% of the control population, a non-
significant difference (Fisher’s exact test
P¼0.783, odds ratio 1.2, 95% confi-
dence interval 0.7–2.1), shown in Table 1.
It is unlikely that our failure to demon-
strate an association has occurred because
of lack of power, as analysis of 256 acne
vulgaris patients and 434 controls, assum-
ing a population prevalence of 88% for
acne vulgaris of comparable severity (Tan
et al., 2007) would give a power of 99%
to detect an odds ratio of 0.3 (Sergeant
et al., 2009) for the combined FLG null
genotype, with two-sided P¼ 0.05. The
equivalent calculation using a popula-
tion prevalence of 23% (based on Singa-
porean teenagers reporting treatment for
their acne (Yosipovitch et al., 2007)) gives
an estimated power of 90% for this study.
Furthermore, the comprehensive screen-
ing of all 22 reported FLG null mutations
from this carefully characterized Singapor-
ean Chinese population means that the
lack of association is unlikely to have
occurred because of incomplete ascertain-
ment of the FLG genotype.
Our finding, that in this Singaporean
Chinese population the frequency of FLG
null mutations in acne vulgaris patients is
not statistically different from the ethni-
cally matched controls, indicates that
filaggrin haploinsufficiency is unlikely to
have a generic protective effect in acne. It
is likely that the overexpression of
filaggrin in the pilosebaceous units re-
ported in the disorder is a bystander
effect, reflecting other alterations in
keratinocyte differentiation, but not itself
critical for acne pathogenesis.
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